Austin, TX -- August 04, 2017 -- InvestorsHub NewsWire -- Wolf Wrangler
 
We’ve got our eyes on Puration, Inc. (USOTC: PURA) and expect to see an announcement coming soon on the Company’s entry into the marijuana pharmaceutical market.d
 
PURA is a highly innovative company with a laser-beam focus on becoming the number one cannabis extract company in the market.  The Company operates a U.S. Patented Cannabis Extraction process for the recreational market today.  Without many food and beverage companies out there yet looking for cannabis extracts to infuse into consumer products, PURA is partnering to help create there first customers.  PURA has been instrumental in the development of the EVERx Cannabis Infused Sports and Fitness Nutritional Supplements consumer product line, in addition to helping to Create Spanish Peaks Cannabis Infused Products, and AmeriCanna Cafe Cannabis Infused Products.  It appears the Company now has its sights set on entering the Marijuana Pharmaceutical sector.
 
The Company just announced the acquisition of a 25 greenhouse grow operation in Texas were the first medical marijuana licenses are to be issued next month. In a presentation on the Company’s website on the strategic plan for the acquisition, it did not slip by us that the Company makes mention of angling to enter the marijuana pharmaceutical market combining their patented cannabis extraction process with the development of their own cannabis strains.  Existing university partnerships have already indicated that the extracts coming from the patented extraction process compare favorably to the extracts from GW Pharmaceuticals (GWPH).  An announcement clarifying specific plans to enter the market alongside GWPH and others such as Medical Marijuana (MJNA) and Cannabis Science (CBIS) could bring new attention to PURA making others see the laser-beam focus and innovation that we believe sets this company apart from other cannabis sector competitors.
 
The Company’s online strategic presentation also highlights a $1.2 million contract signed in conjunction with the 25 greenhouse grow operation, and the potential to rapidly grow revenue from the acquisition to $16 million in annual sales with a longer-term potential to see revenue exceed $100 million in annual sales. 
 
See the recent PURA shareholder presentation on the strategy to grow its recently acquired 25-greenhouse grow operation highlighted in the MMJ Observer Article:
 
Puration’s Grow Operation Business Strategy Overview
 
The Wolves of Wall Street are hard at work cornering their prey – retail investors. We’re not looking to beat the wolves.  We’re looking to pickup their trial and run with the pack as our own breed of hunter.  We’re Wolf Wranglers, recognizing the unchangeable predatory nature of the Wolf and directing it for our own benefit.  If you’re looking to make big returns on small investments as can only be realized on the micro cap public market, then this is the site for you.  Sign-up to share your own opportunity yet undiscovered by the market and to learn from others about opportunities not yet discovered by the market.
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more GW Pharmaceuticals Charts.
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more GW Pharmaceuticals Charts.